Safety Efforts in Pediatric Drug Development
par
Conor D. Byrne
Pas encore d'évaluations
Children’s
Format
Relié
Pages
133
Langue
Slovène
Publié
Jun 1, 2009
Éditeur
Nova Science Pub Inc
Édition
1
ISBN-10
1607415658
ISBN-13
9781607415657
Description
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
Avis
Aucun avis pour le moment
Soyez le premier à donner votre avis sur ce livre et partagez vos pensées
Ajouter le premier avisJournal de lecture
Aucun journal de lecture trouvé
Commencez à suivre vos progrès de lecture pour voir les journaux ici
Ajoutez votre premier journal de lectureNotes
Journal des transactions
Aucun journal de transactions trouvé
Commencez à suivre vos transactions de livres pour voir les journaux ici
Ajoutez votre premier journal de transactions